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New Findings on Sources and
Biokinetics of Lead in Human
Breast Milk: Mother's Bone
Lead Can Target Both Nursing
Infant and Fetus
(See Gulson et al., p. 667)
This issue of Environmental Health
Perspectives includes the latest research
installment in a series of recent findings by
Gulson and co-workers on the quantitative
and temporal aspects of human bone lead
releases during pregnancy and lactation.
Using the technique of stable lead isotope
ratio analysis, Gulson et al. describe bone
lead releases to breast milk and the relation-
ship of such releases to both early infant
lead exposures and overall lead biokinetics
in the early infant. Comparative assessment
is also made of any external lead contribu-
tions to infant lead intakes that would arise
from either breast milk containing maternal
diet lead or direct intake ofexternal lead by
infants ingesting lead in infant formula.
The authors also carried out a critical
appraisal ofthe existing literature on lead in
breast milk, and these earlier data were
placed in context with the present results.
Gulson et al. find that much ofthe lead
ingested by nursing infants arises from
breast milk lead and that a significant frac-
tion ofbreast milk lead arises from continu-
ing bone lead release, although the rate of
release over time may decline. Similarly,
formula-fed infants show blood lead iso-
topic ratios typical of lead in the formula,
but with a high level of variability to be
expected for lead in commercially available
formula from diverse sources. Blood lead
concentrations in infants receiving breast
milk as the nutrition source show dear link-
ages ofbreast milk lead isotopic ratios with
both infant blood and urine, indicating
ready lead bioavailability in the infants. For
mothers, diet lead and breast milk lead lev-
els were correlated as to both concentration
and isotopic ratios.
Overall, ratios of breast milk lead levels
to maternal blood lead concentrations
approximated those of plasma. In these
immigrant subjects, blood lead levels at the
time oflactation were low, producing quite
low breast milk levels, less than 1 ppb on
average. However, it is evidently the case that
where maternal blood lead levels are signifi-
cantly elevated from whatever mix of bone
and diet lead during the nursing period,
breast milklead rises proportionately, akin to
plasma increases. Gulson et al. produce data
in their analysis ofall breast milk lead studies
to show that plotting of the more reliable
earlier data sets along with their results yields
a linear increase when the ratio ofbreast milk
lead to blood lead is plotted against blood
lead. That is, as blood lead rises, the relative
lead amount seen in breast milk compared
to blood lead increases. This would make
breast milk an especially toxic source oflead
for the early infant in those cases where
mothers with nursing infants had high,
chronic lead exposures.
The current study report and earlier
research papers by these investigators
demonstrate the complex biokinetic inter-
play between endogenous lead released
from bone and exogenous lead entering
blood and other body compartments from
(mainly) ingestion for people with diverse
exposure histories. Through extended
funding from the NIEHS, the Australian
team of Gulson and co-workers has been
productively examining the important
issue ofthe role ofaccumulated bone lead
stores in human lead exposure and the
specifics of its potential for release under
diverse external and metabolic circum-
stances over the last 6 or 7 years. Some of
their earlier research directions are the iso-
topic "fingerprinting" of environmental
and tissue lead (1-3), the release of bone
lead when one alters his or her exposure
status (4), additional releases oflead during
pregnancy (5), continued release of bone
lead during lactation (6), and biokinetic
studies oflead in mother/infant pairs (71.
Bone lead is now recognized as being
in equilibrium with lead in blood (8,9),
replacing the traditional, albeit never phys-
iologically plausible, view that lead lodged
in bone was metabolically and toxicologi-
cally inert. Release ofbone lead in humans
during either shifts in (near) steady-state
equilibria with blood lead owing to exter-
nal disturbances such as altered lead
intake/uptake rates, or in response to vari-
ous physiological stimuli and stressors such
as pregnancy, has long been suspected or
suggested in the toxicological and occupa-
tional health literature. This current view
has been slowly developed from informa-
tion based on 1) isolated case reports of
latent lead exposures via elevated blood
lead in individuals exposed in earlier years
but not at testing (10); 2) national epi-
demiological data conveying the inference
that postmenopausal women as a group
show an increase in blood lead that is
explicable in terms of lead releases during
osteoporotic bone demineralization (11);
3) occupational exposures to lead in indi-
viduals whose blood lead and other lead
biomarkers were monitored during retire-
ment (12-14), transitory changes in work-
place contact such as strike actions (15), or
as a function ofexposure duration (15,16);
4) human data indicating increases in
blood lead during pregnancy (17) and
modeling estimates of lead's entry to, and
exit from, bone (18-20).
Clear empirical (epidemiological) docu-
mentation of the phenomenon ofbone lead
remobilization in pregnant and lactating
women and its quantitative biokinetic charac-
terization have until recently evaded easy study
(21). This was so despite experimental animal
evidence suggesting the phenomenon [e.g.,
Keller and Doherty (22)]. By contrast, charac-
terization ofsome ofthe temporal and quanti-
tative features ofthe reverse process, bone lead
accumulation, has advanced farther. The latter
process was favored for study through its
reliance on available autopsy tissue stratified as
to age (23-25), cortical versus trabecular bone
(26), and use of in vivo relatively static mea-
sures oflead accumulation in bone using either
K- (27) orL- (28) X-rayfluorescenceanalysis.
One impediment to the study of bone
lead mobilization, until recently, has been
traditional reliance on conventional total
mass analysis methods for lead quantitation.
For example, incremental changes in total
blood lead concentration during pregnancy
and afterward may not be readily detectable
at lower absolute values without problems
ofprecision and accuracy. More problemat-
ic in using total mass methods is the need
for correct apportionment of the source of
any such incremental rises in blood lead to
either external lead uptake or bone lead
release to blood in pregnancy (and lacta-
tion). Appropriate study control of lead
intakes via duplicate diet lead determina-
tions in pregnancy versus prepregnancy
have not been done other than in the
Gulson et al. research series.
The extent to which maternal lead
absorption through the gut or lung changes
during pregnancy is largely unknown. One
can conclude from the overall information
base in the scientific literature, including
recent information from Gulson et al. (5),
that the overall circulating calcium require-
ment in pregnancy increases owing to fetal
growth requirements; the rate of calcium
intake and/or uptake must thereby increase;
dietary (exogenous) calcium availability is a
determinant in bone calcium (and lead)
release such that more calcium in the diet is
linked to less bone lead release (5); and
amounts of dietary lead absorbed would
increase as calcium uptake increases,
because enteric uptake mechanisms for cal-
cium also favor uptake oflead (29-32).
Changes also occur in body and
hemovascular indices. For example, an
increase in overall blood volume to accom-
modate the placental vascular bed and the
fetal growth rate has long been known.
Hytten (33) has produced estimates of an
approximate change of 50% in plasma vol-
ume from conception to the final trimester
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ofpregnancy, in tandem with only an 18%
increase in erythrocyte mass. Birth weights
and parity status are additional factors that
affect individual circulation indices during
pregnancy (33).
Recent advances in this area ofresearch
represent a textbook illustration ofproduc-
tive collaborations through interdisciplinary
expertise and applications to a multifaceted
problem. The tools and approaches ofgeol-
ogy, geochemistry, and biogeochemistry
have contributed significantly to assessment
ofthe biokinetics ofskeletal lead mobiliza-
tion and its potential role inproducing fetal
and nursing infant lead exposures and poi-
soning risks. In the 1980s, Manton (34)
posited the notion that historical body lead
deposited in bone years ago could be
released through mobilization and provided
evidence for this in a single subject using
stable lead isotope mass spectrometric
quantitation. Rabinowitz (35) developed
the notion further in terms ofmore system-
atic approaches. The stable isotopic lead
ratio approach is relatively complex concep-
tually and computationally, is laborious and
demanding in its requirements for clean-
room methodology to avoid even ultratrace
contamination by lead ofexternal isotopic
ratio origin, and is quite costly on a
unit-sample basis. It remains, nevertheless,
thebestmethodologyto address this topic.
Successful application ofthe stable lead
isotope technique to study of bone lead
remobilization also requires that the iso-
topic composition oflead in bone be both
distinct from external isotopic mixes and
that release be sufficient to permit mass
spectral quantitation ofbone lead releases
within established analytical statistical
bounds for mass spectral methodologies. In
many cases, the required isotopic distinc-
tions do not exist. Epidemiology is still
determined by opportunity, however (36).
Gulson and co-workers were able to exploit
this mass spectral analysis technique within
a multidisciplinary program to study a
recruited population of European immi-
grants to Australia whose bone lead iso-
topic ratios, including that of206Pb/204Pb,
were known to arise from geochemical lead
sources different from lead sources, and
therefore body lead burdens, ofindividuals
who spent their lives inAustralia. The vari-
ous types ofstudies carried out by Gulson
et al. were cited earlier. In summary,
Gulson et al. found that bone lead releases
in adults and children entering Australia
are sufficiently significant that they can
account for up to 70% oftotal blood lead
content, with a persistence over many
months (4). This bone lead release rate in
women of childbearing age is accelerated
during pregnancy in these subjects (5).
Accelerated bone lead release continues
into lactation, and lactation release can in
fact exceed that occurring in pregnancy (6).
The series of bone lead studies by
Gulson and co-workers has a number of
important implications for public health
and lead regulatory policy. I noted some of
these earlier (21). First, bone lead releases in
the Gulson et al. population are significant,
in fractional terms, despite the fact that the
total blood lead concentration was low in
these women. Many women in the Gulson
immigrant group have blood lead values
that would be viewed as largely nontoxic.
Gulson et al. demonstrated that, in preg-
nancy, bone lead is released into maternal
circulation, enters fetal circulation, and is
lodged in thefetus. Similaraccelerated bone
lead releases during lactation extend the
developmental lead exposures to early
infancyviabreast milklead intake.
Total lead transfer to the fetus can be
significant, even when a static measure
such as blood lead appears low. An easier
estimate for the nursing infant milk lead
uptake is possible with estimated ingested
breast milk volumes. Therefore, lead trans-
fers to the fetus from bone, which is fol-
lowed by additional circulating bone lead
entering the nursing infant.
A second issue of concern revolves
around the question ofwhether mobilized
bone lead may in fact exhibit biokinetic
features that result in a higher percentage
of total blood lead being present in the
plasma/serum fraction. This is the fraction
of whole blood lead that comprises the
deliverable lead dose to tissues. Cake et al.
(37) employed serum lead analysis to argue
that, where circulating lead was expected to
mainly represent bone lead rather than cur-
rent exogenous lead uptake, the fraction of
total blood lead in serum is higher than
reported for serum/plasma in ongoing, i.e.,
external exposures. A later Swedish study
(38) and a revisitation of the earlier paper
(37) by some of the original authors (39)
suggested that may not be the case.
However, the two studies differed so wide-
ly as to methodology, design, and subject
exposure profiles that the matter remains
an open question.
High-risk lead exposure populations
still exist in the United States in the form
of inner-city, poor women of childbearing
age, especially those in densely populated
older cities, and other women having local-
ized high lead exposures in communities
affected by lead-emitting industrial opera-
tions or by hazardous waste sites. The col-
lective message from the Gulson et al. stud-
ies is that life-long lead exposures of this
demographically and socioeconomically
diverse risk group must be considered in
determination oflong-term risk assessment
approaches and risk management policies
and initiatives. Lead regulatory and public
health policy initiatives must particularly
encompass a transgenerational time frame
for dealing with lead exposure and lead
toxicity or toxicity risk. Both historical,
endogenous and current exogenous lead
playexposure roles.
The focus of the Gulson studies has
been on the fetus and the nursing infant. It
is critical to point out, however, that
maternal blood lead increases from bone
lead during pregnancy and lactation obvi-
ouslyhave apotential impact as well on the
mother in terms of adverse health effects.
Such toxicological roles for bone lead
releases in incremental maternal blood lead
increases and associated toxicity risks were
recognized and appropriately emphasized
by Silbergeld (40). In some cases, released
lead can affect the health ofthe fetus indi-
rectly by affecting maternal health. Lead is
vasoactive, causing elevations in both sys-
tolic and diastolic blood pressure [see
National Research Council (9) and cita-
tions therein]. Elevations in maternal blood
pressure during pregnancy is an effect of
concern for the mother but is also a known
risk factor for adverse pregnancy outcome,
particularly in the form of retarded fetal
growth that is itselfa risk factor for adverse
developmental effects (41).
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